<DOC>
	<DOCNO>NCT02089308</DOCNO>
	<brief_summary>The purpose study evaluate bioequivalence new transdermal nicotine patch reference formulation follow repeat application</brief_summary>
	<brief_title>Nicotine Patch - Bioequivalence Study</brief_title>
	<detailed_description />
	<mesh_term>Nicotine</mesh_term>
	<criteria>Healthy male subject age 18 45 year ( inclusive ) Current Smoker &gt; = 5 &lt; = 15 cigarettes/day Fagerstr√∂m score &lt; =5 selection Absence clinically significant abnormal finding physical examination , vital sign , Electrocardiogram ECG , biological examination investigator 's opinion . Presence significant medical finding significant history ( particular cardiovascular disease , severe renal hepatic insufficiency , current gastric duodenal ulcer ) may impact safety , interpretation result and/or participation subject study accord opinion investigator Any visible skin disorder , abnormal skin pigmentation dermatologic disease liable interfere use safety assessment transdermal patch</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>June 2014</verification_date>
	<keyword>Smoking cessation</keyword>
	<keyword>Nicotine</keyword>
	<keyword>Tobacco Use Disorder</keyword>
	<keyword>Central Nervous System Agents</keyword>
</DOC>